LONDON--(BUSINESS WIRE)--The global malaria rapid diagnostic devices market is poised to grow by USD 111.63 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period. Request free sample pages
Read the 127-page report with TOC on "Malaria Rapid Diagnostic Devices Market Analysis Report by Product (Consumables and Systems), Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024".
The market is driven by the growing incidence of malaria. In addition, new product launches are anticipated to boost the growth of the malaria rapid diagnostic devices market.
Factors such as the lack of proper healthcare infrastructure and lack of knowledge regarding parasitic infectious diseases have increased the number of malaria cases in countries across Africa and Southeast Asia. The prevalence of malaria is increasing in developed countries as well. For instance, nearly 1,700 cases of malaria are being diagnosed in the US every year. The rising incidence of malaria across countries has increased the demand for malaria rapid diagnostic devices, which can provide quick test results and thus, help in diagnosing the condition. This is one of the key factors driving the growth of the global malaria rapid diagnostic devices market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Malaria Rapid Diagnostic Devices Market Companies:
Abbott Laboratories operates its business through segments such as Established Pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and Neuromodulation. Alere malaria Ag P.f test and BinaxNOW Malaria test are the key offerings of the company.
Atomo Diagnostics operates its business through segments such as OEM DEVICE PLATFORMS, OEM SERVICE, and HIV TESTS. AtomoRapid Malaria is the key product offered by the company.
bioMérieux SA operates its business through segments such as Microbiology, Immunoassays, Molecular Biology, Industrial Applications, and Other Lines. VIKIA Malaria Ag Pf/Pan is the key offering of the company.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. operates its business through segments such as Life Science, Clinical Diagnostics, and Other operations. OptiMAL-IT is the key product offered by the company.
BIOSYNEX SA operates its business through segments such as LABS/HOSPITALS/DOCTORS and PHARMACY/RETAIL. CELLSCHECK is the key product offered by the company.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Malaria Rapid Diagnostic Devices Market Product Outlook (Revenue, USD Billion, 2020-2024)
Malaria Rapid Diagnostic Devices Market Regional Outlook (Revenue, USD Billion, 2020-2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care Include:
Global Bacterial Disease Diagnostics Market – Global bacterial disease diagnostics market by product (instruments and consumables) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.